Subtopic Deep Dive

Cantharidin Protein Phosphatase Inhibition
Research Guide

What is Cantharidin Protein Phosphatase Inhibition?

Cantharidin protein phosphatase inhibition studies the selective inhibition of serine/threonine protein phosphatases PP1 and PP2A by cantharidin, a toxin from blister beetles, and its analogs.

Cantharidin inhibits PP1 and PP2A with IC50 of 0.16 μM for PP2A catalytic subunit (Honkanen, 1993, 286 citations). Research covers structure-activity relationships, binding mechanisms, and effects on cancer cell signaling via G2/M arrest and apoptosis (Li et al., 2010, 183 citations). Over 10 key papers from 1993-2018 document its therapeutic potential.

Curated Papers

Key Challenges

Why It Matters

Cantharidin's PP2A specificity disrupts cancer signaling, inducing G2/M arrest and apoptosis in pancreatic (Li et al., 2010) and colorectal cancer cells (Chen, 2011). Analogs reduce toxicity while retaining efficacy, supporting drug development (Wang et al., 2018; Puerto Galvis et al., 2013). Insights from Honkanen (1993) and Rauh et al. (2007) guide targeted inhibitors for clinical use.

Key Research Challenges

Toxicity Reduction

Cantharidin's high toxicity limits clinical use despite PP2A potency (Wang et al., 2018). Analogs aim to preserve inhibition while minimizing side effects (Puerto Galvis et al., 2013). Structure-activity optimization remains key.

Selectivity Profiling

Distinguishing PP1 vs PP2A inhibition effects is challenging (Honkanen, 1993). Downstream signaling varies by cancer type (Li et al., 2010). Binding mechanism details need refinement.

In Vivo Validation

Cell-based apoptosis data (Chen, 2011; Morana et al., 1996) require animal model confirmation. PP2A regulator dynamics complicate translation (Honkanen and Golden, 2002). Clinical translation lags.

Essential Papers

Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A

Richard E. Honkanen · 1993 · FEBS Letters · 286 citations

Cantharidin, a natural toxicant of blister beetles, is a strong inhibitor of protein phosphatases types 1(PP1) and 2A (PP2A). Like okadaic acid, cantharidin inhibits the activity of the purified ca...

Regulators of Serine / Threonine Protein Phosphatases at the Dawn of a Clinical Era?

Richard E. Honkanen, Teresa Golden · 2002 · Current Medicinal Chemistry · 259 citations

Reversible phosphorylation is a key mechanism for regulating the biological activity of many human proteins that affect a diverse array of cellular processes, including protein-protein interactions...

Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress‐independent growth inhibition of pancreatic cancer cells through G2/M cell‐cycle arrest and apoptosis

Wei Li, Li Xie, Zheng Chen et al. · 2010 · Cancer Science · 183 citations

Cantharidin is an active constituent of mylabris, a traditional Chinese medicine. It is a potent and selective inhibitor of protein phosphatase 2A (PP2A) that plays an important role in control of ...

The Involvement of Protein Phosphatases in the Activation of ICE/CED-3 Protease, Intracellular Acidification, DNA Digestion, and Apoptosis

Salvatore J. Morana, Chad M. Wolf, Jinfang Li et al. · 1996 · Journal of Biological Chemistry · 158 citations

Many events in apoptosis have been identified but their temporal relationships remain obscure. Apoptosis in human ML-1 cells induced by etoposide is characterized by intracellular acidification, en...

The RCN1‐encoded A subunit of protein phosphatase 2A increases phosphatase activity in vivo

Jean Deruère, Karin M. Jackson, Christine Garbers et al. · 1999 · The Plant Journal · 117 citations

Summary Protein phosphatase 2A (PP2A), a heterotrimeric serine/threonine‐specific protein phosphatase, comprises a catalytic C subunit and two distinct regulatory subunits, A and B. The RCN1 gene e...

Cantharidin induces G2/M phase arrest and apoptosis in human colorectal cancer colo 205 cells through inhibition of CDK1 activity and caspase-dependent signaling pathways

Chen · 2011 · International Journal of Oncology · 117 citations

Cantharidin (CTD) is a traditional Chinese medicine and an effective component isolated from blister beetle, and it has been demonstrated to have anticancer, antibiotic, antivirus activities and im...

Molecular biology of cantharidin in cancer cells

Rolf Rauh, Stefan Kahl, Herbert Boechzelt et al. · 2007 · Chinese Medicine · 101 citations

Abstract Herbal medicine is one of the forms of traditional medical practice. Traditional Chinese medicine (TCM) and traditional Vietnamese medicine (TVM) are well-known for their long-standing tra...

Reading Guide

Foundational Papers

Start with Honkanen (1993) for core inhibition data (IC50 values); Honkanen and Golden (2002) for phosphatase regulation context; Li et al. (2010) for cancer applications.

Recent Advances

Wang et al. (2018) overviews analogs; Puerto Galvis et al. (2013) details small-molecule therapeutics.

Core Methods

Enzyme inhibition assays (IC50); cell cycle analysis (G2/M flow cytometry); apoptosis assays (caspase, DNA fragmentation) per Li et al. (2010), Chen (2011).

How PapersFlow Helps You Research Cantharidin Protein Phosphatase Inhibition

Discover & Search

Research Agent uses searchPapers('cantharidin PP2A inhibition IC50') to retrieve Honkanen (1993), then citationGraph reveals 286 citing works and findSimilarPapers uncovers Li et al. (2010). exaSearch scans 250M+ OpenAlex papers for blister beetle analogs.

Analyze & Verify

Analysis Agent applies readPaperContent on Honkanen (1993) to extract IC50 values, verifyResponse with CoVe checks inhibition claims against Li et al. (2010), and runPythonAnalysis plots dose-response curves from extracted data using matplotlib. GRADE grading scores evidence strength for PP2A selectivity.

Synthesize & Write

Synthesis Agent detects gaps in analog toxicity data across Rauh et al. (2007) and Wang et al. (2018), flags contradictions in apoptosis pathways. Writing Agent uses latexEditText for mechanisms, latexSyncCitations for 10+ refs, latexCompile for figures, and exportMermaid for signaling diagrams.

Use Cases

"Extract and plot IC50 values for cantharidin on PP1/PP2A from key papers"

Research Agent → searchPapers → Analysis Agent → readPaperContent (Honkanen 1993) → runPythonAnalysis (pandas plot IC50 curve) → matplotlib figure output.

"Draft LaTeX review on cantharidin analogs in cancer with citations"

Synthesis Agent → gap detection → Writing Agent → latexEditText (structure) → latexSyncCitations (Wang 2018, Puerto Galvis 2013) → latexCompile → PDF review.

"Find GitHub repos analyzing cantharidin docking simulations"

Research Agent → paperExtractUrls (Rauh 2007) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python docking code snippets.

Automated Workflows

Deep Research workflow scans 50+ cantharidin papers via searchPapers → citationGraph, generating structured reports on PP2A inhibition trends. DeepScan's 7-step chain verifies apoptosis mechanisms (Li et al., 2010) with CoVe checkpoints and runPythonAnalysis. Theorizer builds hypotheses on analog binding from Honkanen (1993) data.

Try Doxa for Cantharidin Protein Phosphatase Inhibition Research

Frequently Asked Questions

What defines cantharidin protein phosphatase inhibition?

Cantharidin selectively inhibits PP1 and PP2A from blister beetles, with PP2A IC50=0.16 μM (Honkanen, 1993).

What are main methods studied?

In vitro enzyme assays measure IC50; cell studies track G2/M arrest and apoptosis via caspase activation (Li et al., 2010; Chen, 2011).

What are key papers?

Honkanen (1993, 286 citations) established inhibition; Li et al. (2010, 183 citations) showed cancer effects; Wang et al. (2018, 93 citations) reviewed analogs.